Stem cell therapy for heart diseases

British Medical Bulletin

Volumn 98, Issue 1, 2011, Pages 143-159

  Mozid, Abdul M ^a   Arnous, Samer ^a   Sammut, Eva C ^a   Mathur, Anthony ^a  

^a LONDON CHEST HOSPITAL   (United Kingdom)

Author keywords

acute myocardial infarction; adult stem cell therapy; bone marrow stem progenitor cells; dilated cardiomyopathy; heart failure

Indexed keywords

GRANULOCYTE COLONY STIMULATING FACTOR;

ACUTE HEART INFARCTION; ADIPOSE DERIVED STEM CELL; ADULT STEM CELL; ARTICLE; AUTOLOGOUS STEM CELL TRANSPLANTATION; CLINICAL RESEARCH; CONGESTIVE CARDIOMYOPATHY; EMBRYONIC STEM CELL; FETAL STEM CELL; HEART ASSIST DEVICE; HEART DISEASE; HEART FAILURE; HEART FUNCTION; HEART INFARCTION SIZE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART MUSCLE ISCHEMIA; HEMATOPOIETIC STEM CELL; HUMAN; ISCHEMIC HEART DISEASE; MESENCHYMAL STEM CELL TRANSPLANTATION; MULTIPOTENT STEM CELL; MYOBLAST; NONHUMAN; PEER REVIEW; PLURIPOTENT STEM CELL; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); SMOOTH MUSCLE FIBER; STEM CELL MOBILIZATION; STEM CELL TRANSPLANTATION; TRANSLUMINAL CORONARY ANGIOPLASTY; UMBILICAL CORD; VASCULAR SMOOTH MUSCLE;

CARDIOMYOPATHY, DILATED; CLINICAL TRIALS AS TOPIC; HEART DISEASES; HEART FAILURE; HUMANS; MYOCARDIAL INFARCTION; STEM CELL TRANSPLANTATION;

EID: 79958776453     PISSN: 00071420     EISSN: 14718391     Source Type: Journal    
DOI: 10.1093/bmb/ldr014     Document Type: Article

References (62)

1. World Heal Organisation. The top 10 causes of death. 2008. Ref Type: Online Source
2. Myocardial Ischaemia National Audit Project (MINAP). Annual report. 2010.
3. Davies M, Hobbs F, Davis R et al. Prevalence of left-ventricular systolic dysfunction and heart failure in the Echocardiographic Heart of England Screening study: a population based study. Lancet 2001;358:439-44. (Pubitemid 32769849)
4. Fox KF, Cowie MR, Wood DA et al. Coronary artery disease as the cause of incident heart failure in the population. Eur Heart J 2001;22:228-36. (Pubitemid 32622473)
5. Cowie MR, Mosterd A, Wood DA et al. The epidemiology of heart failure. Eur Heart J 1997;18:208-25. (Pubitemid 27107582)
6. Allender S, Peto V, Scarborough P et al. Coronary heart disease statistics. BHF 2008. Chapter 13.
7. Beltrami AP, Barlucchi L, Torella D et al. Adult cardiac stem cells are multipotent and support myocardial regeneration. Cell 2003;114:763-76. (Pubitemid 37186770)
8. Orlic D, Kajstura J, Chimenti S et al. Bone marrow cells regenerate infarcted myocardium. Nature 2001;410:701-5 (Pubitemid 32290358)
9. Xu C, Police S, Rao N et al. Characterization and enrichment of cardiomyocytes derived from human embryonic stem cells. Circ Res 2002;91:501-8.
10. Klug MG, Soonpaa MH, Koh GY et al. Genetically selected cardiomyocytes from differentiating embronic stem cells form stable intracardiac grafts. J Clin Invest 1996;98:216-24. (Pubitemid 26243839)
11. Lee AS, Tang C, Cao F et al. Effects of cell number on teratoma formation by human embryonic stem cells. Cell Cycle 2009;8:2608-12.
12. Takahashi K, Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 2006;126:663-76. (Pubitemid 44233629)
13. Aasen T, Raya A, Barrero MJ et al. Efficient and rapid generation of induced pluripotent stem cells from human keratinocytes. Nat Biotechnol 2008;26:1276-84.
14. Takahashi K, Tanabe K, Ohnuki M et al. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 2007;131:861-72. (Pubitemid 350138099)
15. Zhang J, Wilson GF, Soerens AG et al. Functional cardiomyocytes derived from human induced pluripotent stem cells. Circ Res 2009;104:e30-41.
16. Scorsin M, Hagege AA, Marotte F et al. Does transplantation of cardiomyocytes improve function of infarcted myocardium? Circulation 1997;96(9 Suppl):II-93.
17. Li RK, Jia ZQ, Weisel RD et al. Cardiomyocyte transplantation improves heart function. Ann Thorac Surg 1996;62:654-60.
18. Gluckman E. Ten years of cord blood transplantation: from bench to bedside. Br J Haematol 2009;147:192-9.
19. Henning RJ, Burgos JD, Vasko M et al. Human cord blood cells and myocardial infarction: effect of dose and route of administration on infarct size. Cell Transplant 2007;16:907-17. (Pubitemid 351448608)
20. Beltrami AP, Urbanek K, Kajstura J et al. Evidence that human cardiac myocytes divide after myocardial infarction. N Eng J Med 2001;344:1750-7. (Pubitemid 32497029)
21. Messina E, De AL, Frati G et al. Isolation and expansion of adult cardiac stem cells from human and murine heart. Circ Res 2004;95:911-21. (Pubitemid 39435006)
22. Oh H, Bradfute SB, Gallardo TD et al. Cardiac progenitor cells from adult myocardium: homing, differentiation, and fusion after infarction. Proc Natl Acad Sci USA 2003;100:12313-8. (Pubitemid 37271557)
23. Wang L, Deng J, Tian W et al. Adipose-derived stem cells are an effective cell candidate for treatment of heart failure: an MR imaging study of rat hearts. Am J Physiol Heart Circ Physiol 2009;297:H1020-31.
24. Valina C, Pinkernell K, Song YH et al. Intracoronary administration of autologous adipose tissue-derived stem cells improves left ventricular function, perfusion, and remodelling after acute myocardial infarction. Eur Heart J 2007;28:2667-77. (Pubitemid 350071533)
25. Taylor DA, Atkins BZ, Hungspreugs P et al. Regenerating functional myocardium: improved performance after skeletal myoblast transplantation. Nat Med 1998;4:929-33. (Pubitemid 28364032)
26. Dib N, Michler RE, Pagani FD et al. Safety and feasibility of autologous myoblast transplantation in patients with ischemic cardiomyopathy: four-year follow-up. Circulation 2005;112:1748-55. (Pubitemid 41368151)
27. Menasche P, Alfieri O, Janssens S et al. The Myoblast Autologous Grafting in Ischemic Cardiomyopathy (MAGIC) trial: first randomized placebo-controlled study of myoblast transplantation. Circulation 2008;117:1189-200. (Pubitemid 351552018)
28. Balsam LB, Wagers AJ, Christensen JL et al. Haematopoietic stem cells adopt mature haematopoietic fates in ischaemic myocardium. Nature 2004;428:668-73. (Pubitemid 38524811)
29. Murry CE, Soonpaa MH, Reinecke H et al. Haematopoietic stem cells do not transdifferentiate into cardiac myocytes in myocardial infarcts. Nature 2004;428:664-8. (Pubitemid 38524810)
30. Dimmeler S, Zeiher AM, Schneider MD. Unchain my heart: the scientific foundations of cardiac repair. J Clin Invest 2005;115:572-83. (Pubitemid 40322227)
31. Hare JM, Traverse JH, Henry TD et al. A randomized, double-blind, placebo-controlled, dose-escalation study of intravenous adult human mesenchymal stem cells (prochymal) after acute myocardial infarction. J Am Coll Cardiol 2009;54:2277-86.
32. Gao J, Dennis JE, Muzic RF et al. The dynamic in vivo distribution of bone marrow-derived mesenchymal stem cells after infusion. Cells Tissues Organs 2001;169:12-20. (Pubitemid 32437040)
33. Orlic D, Kajstura J, Chimenti S et al. Mobilized bone marrow cells repair the infarcted heart, improving function and survival. Proc Natl Acad Sci USA 2001;98:10344-9. (Pubitemid 32803022)
34. Ince H, Petzsch M, Kleine HD et al. Prevention of left ventricular remodeling with granulocyte colony-stimulating factor after acute myocardial infarction: final 1-year results of the Front-Integrated Revascularization and Stem Cell Liberation in Evolving Acute Myocardial Infarction by Granulocyte Colony-Stimulating Factor (FIRSTLINE-AMI) Trial. Circulation 2005;112(9 Suppl):I73-80. (Pubitemid 41266656)
35. Abdel-Latif A, Bolli R, Zuba-Surma EK et al. Granulocyte colony-stimulating factor therapy for cardiac repair after acute myocardial infarction: a systematic review and meta-analysis of randomized controlled trials. Am Heart J 2008;156:216-26.
36. Vulliet PR, Greeley M, Halloran SM et al. Intra-coronary arterial injection of mesenchymal stromal cells and microinfarction in dogs. Lancet 2004;363:783-4. (Pubitemid 38315169)
37. Martin-Rendon E, Brunskill SJ, Hyde CJ et al. Autologous bone marrow stem cells to treat acute myocardial infarction: a systematic review. Eur Heart J 2008;29:1807-18.
38. Makela J, Anttila V, Ylitalo K et al. Acute homing of bone marrow-derived mononuclear cells in intramyocardial vs. intracoronary transplantation. Scand Cardiovasc J 2009;43:366-73.
39. Teng CJ, Luo J, Chiu RC et al. Massive mechanical loss of microspheres with direct intramyocardial injection in the beating heart: implications for cellular cardiomyoplasty. J Thorac Cardiovasc Surg 2006;132:628-32. (Pubitemid 44278933)
40. Pfeffer MA, McMurray JJ, Velazquez EJ et al. Valsartan, captopril, or both in myocardial infarction complicated by heart failure, left ventricular dysfunction, or both. N Engl J Med 2003;349:1893-906. (Pubitemid 37409706)
41. Assmus B, Schächinger V, Teupe C et al. Transplantation of Progenitor Cells and Regeneration Enhancement in Acute Myocardial Infarction (TOPCARE-AMI). Circulation 2002;106:3009-17. (Pubitemid 35440281)
42. Wollert KC, Meyer GP, Lotz J et al. Intracoronary autologous bone-marrow cell transfer after myocardial infarction: the BOOST randomised controlled clinical trial. Lancet 2004;364:141-8. (Pubitemid 38891685)
43. Schächinger V, Erbs S, Elsä sser A et al. Intracoronary bone marrow-derived progenitor cells in acute myocardial infarction. N Eng J Med 2006;355:1210-21.
44. Huikuri HV, Kervinen K, Niemelä M et al. Effects of intracoronary injection of mononuclear bone marrow cells on left ventricular function, arrhythmia risk profile, and restenosis after thrombolytic therapy of acute myocardial infarction. Eur Heart J 2008;29:2723-32.
45. Janssens S, Dubois C, Bogaert J et al. Autologous bone marrow-derived stem-cell transfer in patients with ST-segment elevation myocardial infarction: double-blind, randomised controlled trial. Lancet 2006;367:113-21. (Pubitemid 43077127)
46. Lunde K, Solheim S, Aakhus S et al. Intracoronary injection of mononuclear bone marrow cells in acute myocardial infarction. N Eng J Med 2006;355:1199-209. (Pubitemid 44427444)
47. Hirsch A, Nijveldt R, van der Vleuten PA et al. Intracoronary infusion of mononuclear cells from bone marrow or peripheral blood compared with standard therapy in patients after acute myocardial infarction treated by primary percutaneous coronary intervention: results of the randomized controlled HEBE trial. Eur Heart J 2010 [Epub ahead of print].
48. Dib N, Dinsmore J, Lababidi Z et al. One-year follow-up of feasibility and safety of the first U.S., randomized, controlled study using 3-dimensional guided catheter-based delivery of autologous skeletal myoblasts for ischemic cardiomyopathy (CAuSMIC study). JACC Cardiovasc Interv 2009;2:9-16.
49. Galiñ anes M, Loubani M, Davies J et al. Autotransplantation of unmanipulated bone marrow into scarred myocardium is safe and enhances cardiac function in humans. Cell Transplant 2004;13:7-13.
50. Ang KL, Chin D, Leyva F et al. Randomized, controlled trial of intramuscular or intracoronary injection of autologous bone marrow cells into scarred myocardium during CABG versus CABG alone. Nat Clin Pract Cardiovasc Med 2008;5:663-70.
51. Stamm C, Kleine HD, Choi YH et al. Intramyocardial delivery of CD133\+ bone marrow cells and coronary artery bypass grafting for chronic ischemic heart disease: safety and efficacy studies. J Thorac Cardiovasc Surg 2007;133:717-25.
52. Assmus B, Honold J, Schachinger V et al. Transcoronary transplantation of progenitor cells after myocardial infarction. N Eng J Med 2006;355:1222-32. (Pubitemid 44427446)
53. Strauer BE, Yousef M, Schannwell CM. The acute and long-term effects of intracoronary Stem cell Transplantation in 191 patients with chronic heARt failure: the STAR-heart study. Eur J Heart Fail 2010;12:721-9.
54. Yeo C, Mathur A. Autologous bone marrow-derived stem cells for ischemic heart failure: REGENERATE-IHD trial. Regen Med 2009;4:119-27.
55. Ahmad F, Seidman JG, Seidman CE. The genetic basis for cardiac remodeling. Annu Rev Genomics Hum Genet 2005;6:185-216. (Pubitemid 41397081)
56. Taylor DO, Edwards LB, Boucek MM et al. Registry of the International Society for Heart and Lung Transplantation: twenty-second official adult heart transplant report-2005. J Heart Lung Transplant 2005;24:945-55. (Pubitemid 41127174)
57. Yamada S, Nelson TJ, Crespo-Diaz RJ et al. Embryonic stem cell therapy of heart failure in genetic cardiomyopathy. Stem Cells 2008;26:2644-53.
58. Nagaya N, Kangawa K, Itoh T et al. Transplantation of mesenchymal stem cells improves cardiac function in a rat model of dilated cardiomyopathy. Circulation 2005;112:1128-35. (Pubitemid 41216119)
59. Seth S, Narang R, Bhargava B et al. Percutaneous intracoronary cellular cardiomyoplasty for nonischemic cardiomyopathy: clinical and histopathological results: the first-in-man ABCD (Autologous Bone Marrow Cells in Dilated Cardiomyopathy) trial. J Am Coll Cardiol 2006;48:2350-1. (Pubitemid 44855430)
60. Fischer-Rasokat U, Assmus B, Seeger FH et al. A pilot trial to assess potential effects of selective intracoronary bone marrow-derived progenitor cell infusion in patients with nonischemic dilated cardiomyopathy: final 1-year results of the transplantation of progenitor cells and functional regeneration enhancement pilot trial in patients with nonischemic dilated cardiomyopathy. Circ Heart Fail 2009;2:417-23.
61. Bartunek J, Dimmeler S, Drexler H et al. The consensus of the task force of the European Society of Cardiology concerning the clinical investigation of the use of autologous adult stem cells for repair of the heart. Eur Heart J 2006;27:1338-40. (Pubitemid 43998109)
62. Isner JM. Myocardial gene therapy. Nature 2002;415:234-9. (Pubitemid 34059530)